ADPKD, Tolvaptan, and Nephrolithiasis Risk.
ADPKD, Tolvaptan, and Nephrolithiasis Risk.
Clin J Am Soc Nephrol. 2020 Jun 11;:
Authors: Hoorn EJ, Zietse R
PMID: 32527947 [PubMed - as supplied by publisher]
Source: Clinical Journal of the American Society of Nephrology : CJASN - Category: Urology & Nephrology Authors: Hoorn EJ, Zietse R Tags: Clin J Am Soc Nephrol Source Type: research
More News: Kidney Stones | Urology & Nephrology